Indian CDMO Gland Pharma to acquire French CDMO Cenexi

Raghuram Kadari- November 30, 2022 0

Gland Pharma, an Indian contract development and manufacturing organization (CDMO), through its Singapore subsidiary Gland Pharma International, has agreed to acquire Cenexi, a French CDMO, ... Read More

Biocon Biologics wraps up $3.3bn acquisition of Viatris biosimilars unit

Pallavi Madhiraju- November 30, 2022 0

Biocon said that its subsidiary Biocon Biologics has wrapped up the previously announced $3.3 billion acquisition of the biosimilars business of US-based pharma company Viatris. ... Read More

Lupin subsidiary MedQuímica buys rights to nine drugs from Bausch Health

Pallavi Madhiraju- November 29, 2022 0

Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights to nine drugs from Bausch Health Companies’ ... Read More

Alcon acquires Aerie Pharmaceuticals to expand eye care business

Raghuram Kadari- November 24, 2022 0

Alcon, an American Swiss medical company specializing in eye care products, has closed the previously announced $930 million acquisition of Aerie Pharmaceuticals, a NASDAQ-based pharmaceutical ... Read More

Merck to acquire Imago BioSciences to expand blood disorder drugs portfolio

Raghuram Kadari- November 23, 2022 0

Pharma giant Merck will acquire Imago BioSciences, a Nasdaq-listed clinical stage biopharmaceutical company, for a price of $36 per share in cash, which translates to ... Read More

Astellas Pharma to acquire stake in biotech company Taysha GeneTherapies

Raghuram Kadari- October 26, 2022 0

Astellas Pharma has signed an agreement to acquire a 15% stake in US-based biotech company Taysha GeneTherapies through an investment of $50 million. As part ... Read More

Sumitovant Biopharma to take full ownership of Myovant Sciences for $1.7bn

Pallavi Madhiraju- October 24, 2022 0

Sumitovant Biopharma, a subsidiary of Japan-based Sumitomo Pharma (previously Sumitomo Dainippon Pharma), is set to take full ownership of Myovant Sciences, an American publicly-listed biopharma ... Read More

Clinical-stage pharma firms Ayala Pharmaceuticals, Advaxis sign merger deal

Pallavi Madhiraju- October 22, 2022 0

Ayala Pharmaceuticals, a Nasdaq-listed clinical-stage oncology company, has entered into a merger deal with New Jersey-based biotech company Advaxis. Based in Delaware, Ayala Pharmaceuticals is ... Read More

AbbVie acquires UK biotech company DJS Antibodies for $255m

Raghuram Kadari- October 21, 2022 0

AbbVie has acquired DJS Antibodies, a privately-held UK-based biotech company, in an all-cash transaction valued at approximately $255 million, in a move to further strengthen ... Read More

Lupin to acquire rights to Brovana and Xopenex HFA for $75m

Pallavi Madhiraju- October 20, 2022 0

Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) ... Read More